Hong Seng to acquire 51% in RZAC

PETALING JAYA: Hong Seng Consolidated Bhd’s wholly-owned subsidiary, HS Bio Sdn Bhd, has signed a heads of agreement following a proposed acquisition of 51% shareholdings in RZAC Immunesafe Sdn Bhd for RM40.3mil.

In a filing with Bursa Malaysia yesterday, the company said the agreement was signed with Datuk Seri Shahril Mokhtar, Datuk Wan Khalik Wan Muhammad and RZAC Business Sdn Bhd. – Bernama

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Hong Seng Consolidated , Shahril Mokhtar , HS Bio ,

Next In Business News
MSPO certification helps Malaysia meet sustainability requirements in FTAs, says MPOB
Teamstar signs underwriting agreement with TA Securities for ACE Market IPO
Melati Ehsan redesignates COO to CEO
TM Nxera partners with TNB to secure 280MW for data centre campus
Favelle Favco acquires France-based Seram Industries SAS
Ringgit ends firmer as concerns over Fed independence weigh on US dollar
HE Group wins power distribution system contract
Awanbiru appoints Azizah Ali as its group CEO
MN Holdings proposes transfer to the Main Market of Bursa Securities
Vantris Energy divests stake in L&T-Sapura Shipping for 124mil

Trending in Business

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.